Clinical Trial Update: Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients [Phase 1]

View source ↗

Summary

This update discusses a Phase 1 clinical trial evaluating GX-12 gene therapy in combination with HAART for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GX-12 (GX-12)

Snippet

Sponsor: Genexine, Inc. | Conditions: HIV Infections | Phase 1 | Status: UNKNOWN